Actively Recruiting
Virtual Reality Therapy for Cancer-Treatment Associated Symptoms
Led by University of Maryland, Baltimore · Updated on 2026-04-29
30
Participants Needed
2
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
We propose an innovative approach to symptom management in cancer patients following cancer treatments, utilizing a Multimodal Integrative Therapy (MIT) delivered via Virtual Reality (VR) program, authorized by the US Food and Drug Administration for in-home use. Our primary goal is to generate pilot data on the effects of MIT-VR program on pain, fatigue, sleep, depression, and anxiety in participants suffering from chronic cancer symptoms following cancer treatments.
CONDITIONS
Official Title
Virtual Reality Therapy for Cancer-Treatment Associated Symptoms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults ages 18 to 88 years
- Verified cancer diagnosis
- Completed surgical intervention, chemotherapy, or radiation for cancer treatment
- At least 3 months since last cancer treatment; ongoing endocrine or immunotherapy allowed
- Documented symptoms from cancer or treatment including pain, anxiety, sleep difficulty, fatigue, or neuropathy
- Able to speak and understand written English
You will not qualify if you...
- Severe psychiatric condition requiring hospitalization in past 3 years
- Personal or first-degree family history of mania, schizophrenia, or other psychoses
- Diagnosis and treatment of chronic pain, neuropathy, fatigue, sleep, or anxiety disorder before cancer diagnosis
- Currently receiving hospice or palliative care only
- Color-blindness
- Impaired or uncorrected hearing
- Lifetime alcohol or drug dependence or abuse in past 3 months
- Conditions preventing VR mask use such as trauma, burns, or infection
- Known history of severe motion sickness
- Pregnancy or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Luana Colloca
Baltimore, Maryland, United States, 21201-1512
Actively Recruiting
2
University of Maryland
Baltimore, Maryland, United States, 21201-1512
Actively Recruiting
Research Team
K
Katia Matychak, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here